0001144204-19-000676.txt : 20190104
0001144204-19-000676.hdr.sgml : 20190104
20190104163231
ACCESSION NUMBER: 0001144204-19-000676
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190104
DATE AS OF CHANGE: 20190104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SKELLY WILLIAM G
CENTRAL INDEX KEY: 0001058352
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10113
FILM NUMBER: 19510519
MAIL ADDRESS:
STREET 1: C/O ACURA PHARMACEUTICALS, INC.
STREET 2: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACURA PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0000786947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 110853640
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
CITY: PALATINE
STATE: IL
ZIP: 60067
BUSINESS PHONE: 847-705-7709
MAIL ADDRESS:
STREET 1: 616 N. NORTH COURT, SUITE 120
STREET 2: .
CITY: PALATINE
STATE: IL
ZIP: 60067
FORMER COMPANY:
FORMER CONFORMED NAME: HALSEY DRUG CO INC/NEW
DATE OF NAME CHANGE: 19920703
4
1
tv510423_4.xml
OWNERSHIP DOCUMENT
X0306
4
2019-01-02
0
0000786947
ACURA PHARMACEUTICALS, INC
ACUR
0001058352
SKELLY WILLIAM G
C/O ACURA PHARMACEUTICALS, INC.
616 N. NORTH COURT SUITE 120
PALATINE
IL
60067
1
0
0
0
Common Stock
2019-01-02
4
M
0
66666
A
254534
D
Restricted Stock Units (2017 Plan)
2019-01-02
4
M
0
66666
D
Common Stock
66666
0
D
Restricted Stock Units (2017 Plan)
2019-01-02
4
A
0
83333
A
Common Stock
83333
83333
D
Represents exchange of restricted stock units.
Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
Does not include Restricted Stock Units.
1 - for - 1
25% of Restricted Stock Units vested on March 31, 2018, 25% vested on June 30, 2018; 25% vested on September 30, 2018 and 25% vested on December 31, 2018. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
N/A
25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2019, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2020, or earlier upon a change of control.
/s/ William Skelly
2019-01-03